Enter your login e-mail to the account
Search
Search parameters
Search results
- Secondary osteoporosis in patients with malignancies
MUDr. Beata Špániková, PhD.
(1/2018, Interdisciplinary consilium ) - Current options of conservative treatment of benign hyperplasia of prostate
Doc. MUDr. Jozef Marenčák, PhD.
(1/2018, Interdisciplinary consilium ) - New imaging methods in the diagnosis of prostate cancer
doc. MUDr. Jozef Marenčák, PhD.
(6/2023, Interdisciplinary consilium ) - Urinary incontinence after prostate surgery
Doc. MUDr. Jozef Marenčák, PhD.
(5/2020, Interdisciplinary consilium ) - Včasný záchyt karcinómu prostaty – úloha všeobecného lekára
Doc. MUDr. Jozef Marenčák, PhD.
(4/2018, Interdisciplinary consilium ) - DIAGNOSIS AND TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AT PRESENT
MUDr. Milan Blaško, MUDr. Marián Hladík, MUDr. Ján Hoffmann, MUDr. Peter Kertes
(9/2007, Topic ) - PROSTATE CANCER
MUDr. Peter Kertes, Milan Blaško, Marián Hladík, Ján Hoffmann
(9/2007, Topic ) - INFECTION OF THE LOWER URINARY TRACT
MUDr. Milan Blaško, MUDr. Marián Hladík, MUDr. Ján Hoffmann, MUDr. Peter Kertes
(9/2007, Topic ) - Osteoporosis pharmacotherapy and adherence of patient
prof. MUDr. Juraj Payer, CSc., MUDr. Kristína Brázdilová, MUDr. Peter Jackuliak, doc. MUDr. Zdenko Killinger, PhD.
(5/2010, Review articles ) - Clinical importance of testosterone in the aging male from urological viewpoint
Doc. MUDr. Jozef Marenčák, PhD.
(2/2017, Interdisciplinary consilium ) - Practical approach to diagnosis and treatment of prostate cancer
prof. MUDr. Ján Kliment, CSc.
(5/2012, Review articles ) - New possibilities of VTE prophylaxis and treatment for the knee and hip arthroplasty in orthopedic surgery
prof. MUDr. Peter Kubisz, DrSc., MUDr. Daniela Kotuličová, MUDr. Ján Staško, PhD.
(7-8/2009, Review articles ) - Prostate cancer
doc. MUDr. Jozef Marenčák, PhD.
(3/2010, Review articles ) - New trends in metastatic hormone-sensitive prostate cancer treatment
prof. MUDr. Ján Kliment, CSc.
(2/2020, Interdisciplinary consilium ) - Obesity from andrologist point of view
MUDr. Igor Bartl, PhD.
(4/2024, Topic of the year ) - Tlačové správy
(4/2010, Information & comments ) - Non-pharmacological treatment of prostate cancer
Doc. MUDr. Jozef Marenčák, PhD.
(4/2021, Interdisciplinary consilium ) - Stress urinary incontinence in men
Doc. MUDr. Jozef Marenčák, PhD.
(3/2019, Interdisciplinary consilium ) - Substitute therapy with androgenes
MUDr. Vladimír Kubíček, CSc.
(5/2009, Interdisciplinary consilium ) - How early diagnose urological malignancy in the office of a general practitioner
doc. MUDr. Jozef Marenčák, PhD.
(5/2014, Review articles ) - Benign prostatic hyperplasia, diagnostics and contemporary opportunities of miniinvasive treatment
MUDr. Jiří Klečka, Ph.D., MUDr. Petr Běhounek, doc. MUDr. Milan Hora, Ph.D., MUDr. Viktor Eret
(1/2011, Interdisciplinary consilium ) - Phytotherapy of benign prostate hyperplasia
PharmDr. Silvia Fialová, PhD.
(2/2013, Interdisciplinary consilium )
- METABOLIC SYNDROME AND SELECTED MENTHAL ILLNESSES
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(4/2008, Review articles )
- Chronic subdural haematoma associated with advanced malignant tumor
prof. MUDr. Markéta Hermanová, Ph.D., MUDr. Dušan Hrabovský, doc. MUDr. Radim Jančálek, Ph.D., MUDr. Petr Burkoň, Ph.D., doc. MUDr. Jan Chrastina, Ph.D.
(2/2016, Case reports )
- PROSTATIC SYNDROME – ASYMPTOMATIC PROSTATITIS
MUDr. Kamil Belej, FEBU
(5-6/2007, Review articles ) - ACTUAL MEDICATION OF THE BONE METASTASE
MUDr. Ivan Kolombo, FEBU, MUDr. Martina Poršová, MUDr. Jaroslav Porš, MUDr. Richard Pabišta
(5-6/2007, Review articles ) - Androgen deprivation therapy of prostate cancer and cardiovascular morbidity
MUDr. Otakar Čapoun, Ph.D., FEBU
(4/2019, Review articles ) - New treatment options in hormone-sensitive prostate cancer
MUDr. Otakar Čapoun, Ph.D., FEBU
(5/2019, Review articles ) - Ten years of permanent brachytherapy for prostate cancer in Czech Republic
doc. MUDr. Renata Soumarová, Ph.D., MBA, MUDr. Tomáš Blažek
(5/2019, Review articles ) - Risks of non-quinolone prophylaxis for transrectal ultrasoud guiled prostate biopsy
MUDr. Michal Balik, MUDr. Jaroslav Pacovský, Ph.D., doc. MUDr. Miloš Broďák, Ph.D., doc. MUDr. Helena Žemličková, Ph.D.
(1/2018, Review articles ) - Effectiveness and safety of abiraterone acetate treatment for metastatic castration-resistant prostate cancer post-chemotherapy
MUDr. Tomáš Hradec, FEBU, MUDr. Otakar Čapoun, FEBU
(2/2018, Review articles ) - Proton-beam therapy controversies in prostate cancor
prof. MUDr. Jiří Petera, Ph.D., doc. MUDr. Miloš Broďák, Ph.D., MUDr. Jan Pokorný, FEBU, MBA, MUDr. Michaela Matoušková, Vlasta Králová
(2/2018, Review articles ) - Increasing the accuracy of prostate cancer diagnostics by glycoprofiling of selected serum oncomarkers: clinical and economic impact per patient
Ing. Tomáš Bertók, PhD., MUDr. Roman Sokol, PhD., MPH, doc. MUDr. Juraj Fillo, CSc., Ing. Ján Tkáč, DrSc.
(4/2023, Review articles ) - Prostatitis – practical notes to diagnostics and treatment
MUDr. Martina Poršová, MUDr. Ivan Kolombo, FEBU, MUDr. Jaroslav Porš
(2/2018, In short ) - Serum markers in diagnosing prostate cancer
MUDr. Aneta Rozsypalová
(4/2023, From the frontier of urology ) - Minimally invasive treatment of urinary retention in an eldery man with comorbities
prof. MUDr. Miloš Broďák, Ph.D., MUDr. Vendelín Chovanec, Ph.D., prof. MUDr. Antonín Krajina, CSc.
(4/2023, Communication from practice ) - The role of pelvic lymphadenectomy in the treatment of prostate cancer
MUDr. Vladimír Študent, Ph.D., FEBU, ml., doc. MUDr. Zbyněk Tüdös, Ph.D., MUDr. Zuzana Seifriedová, MUDr. Hana Študentová, Ph.D., Mgr. Dana Purová, prof. MUDr. Vladimír Študent, Ph.D.
(3/2021, Review articles ) - Diagnostic algorithms in prostate cancer – 2nd part
MUDr. Otakar Čapoun, Ph.D., FEBU
(3/2021, In short ) - Peritoneal flap fixation: effect on the prevention of lymphocele formation after radical prostatectomy with lymphadenectomy
MUDr. Vladimír Študent, Ph.D., FEBU, doc. MUDr. Zbyněk Tüdös, Ph.D., MUDr. Zuzana Seifriedová, MUDr. Hana Študentová, Ph.D., Mgr. Dana Purová, prof. MUDr. Vladimír Študent, Ph.D.
(4/2021, Review articles ) - Transitional cell carcinoma of the prostate
MUDr. Přemysl Grubský ml., MUDr. Abdulbaset Hafuda, MUDr. Vojtěch Mezera, Ph.D., MUDr. Ivan Kolombo, FEBU, MUDr. Jiří Vorlíček
(4/2021, Communication from practice ) - Synchronous tumor duplicity of prostate and rectum carcinoma
MUDr. Pavel Škrobánek
(1/2023, Communication from practice ) - Is age the limitation of metastatic treatment prostate cancer?
MUDr. Jana Katolická, Ph.D.
(5/2018, Review articles ) - Vitamin D3, its aspect and possible use for urology
doc. MUDr. Juraj Fillo, PhD., MPH, MUDr. Michaela Levčíková
(5/2018, Practical advice ) - Therapy of prostate cancer in elderly patients
MUDr. Otakar Čapoun, Ph.D., FEBU
(3/2022, Review articles ) - MRI targeted triopsy of the prostate – 1st part
MUDr. Šarka Kudlačkova, doc. MUDr. František Zaťura, Ph.D., MUDr. Zbyněk Tüdös, Ph.D.
(2/2017, Review articles ) - PROSTATIC SYNDROME – BACTERIAL INFLAMATION
MUDr.Kamil Belej, FEBU
(3/2007, Review articles ) - BENIGN PROSTATE HYPERTROPHY AND CONTEMPORARY TREND IN THE TREATMENT
doc. MUDr. Milan Hora, Ph.D., MUDr. Jiří Klečka
(3/2007, Review articles ) - Non-metastatic castration-resistant prostate cancer
MUDr. Jana Katolická, Ph.D.
(2/2022, Review articles ) - HORMONAL MILIEU OF PROSTATE CANCER AND NEW OPTIONS FOR ITS MANAGEMENT
MUDr. Michaela Matoušková
(3/2007, Review articles ) - PARP inhibitors in treating metastatic castration-resistant prostate cancer
MUDr. Igor Richter, Ph.D., doc. MUDr. Josef Dvořák, Ph.D., MUDr. Vladimír Šámal, Ph.D., MUDr. Jiří Bartoš, MBA, MUDr. Sofya Al-Samsam
(3/2023, Review articles ) - Current perspective on transurethral enucleation procedures on prostate in benign prostatic hyperplasia
MUDr. Vladimír Valter, MUDr. Miroslav Krhovský
(3/2023, Review articles ) - DIAGNOSIS AND TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AT PRESENT
MUDr. Milan Blaško, MUDr. Marián Hladík, MUDr. Ján Hoffmann, MUDr. Peter Kertes
(4/2007, Review articles ) - PROSTATIC SYNDROME – SYNDROME OF CHRONIC PELVIC PAIN
MUDr. Kamil Belej, FEBU
(4/2007, Review articles ) - NUTRITION FACTORS IN ETIOPATHOGENESIS OF PROSTATE CANCER
doc. MUDr. Ladislav Jarolím, CSc., doc. MUDr. Ivan Kawaciuk, CSc., MUDr. Matúš Chocholatý, MUDr. Marek Schmidt, FEBU, MUDr. Štěpán Veselý, Ph.D
(4/2007, Review articles ) - SEMINOM PROSTATY
doc. MUDr. Ladislav Jarolím, CSc., doc. MUDr. Ivan Kawaciuk, CSc., MUDr. Pavel Dušek, MUDr. Pavel Hanek
(4/2007, Case reports ) - 18F-fluciclovine PET/CT in prostate cancer
MUDr. Václav Ptáčník, MUDr. David Zogala
(1/2021, Review articles ) - GLEASONOVO SKÓRE V BIOPSII A PO RADIKÁLNÍ PROSTATEKTOMII - ZMĚNY PO KONFERENCI ISUP 2005 A VÝZNAM PRE UROLÓGA
MUDr. Milan Král, doc. MUDr. Vladimír Študent, Ph.D., MUDr. Aleš Vidlář, MUDr. Daniela Kurfűrstová, MUDr. Ladislava Kučerová
(4/2007, Case reports ) - OBOUSTRANNÁ GRANULOMATÓZNÍ ORCHIEPIDIDYMITIS JAKO KOMPLIKACE BCG LÉČBY POVRCHOVÉHO KARCINOMU MOČOVÉHO MĚCHÝŘE
MUDr. Tomáš Dvořák, MUDr. Jan Schraml, MUDr. Václav Hynek, MUDr. Michal Hálek, MUDr. Krišna Sapkota, MUDr. František Kunec, MUDr. Eva Sticová
(4/2007, Case reports ) - HORMONAL REGULATIONS AND POSSIBILITIES OF INTERVENTION IN PROSTATE CANCER TREATMENT
MUDr. Kamil Belej, FEBU, , MUDr. Ondřej Kaplan
(1/2008, Review articles ) - MRI targeted biopsy of the prostate – 2nd part: fusion techniques
MUDr. Šarka Kudlačkova, doc. MUDr. František Zaťura, PhD.
(5/2017, Review articles ) - PREDIKČNÍ NOMOGRAMY U KARCINOMU PROSTATY
MUDr. Milan Král,, doc. MUDr. Vladimír Študent, Ph.D, MUDr. Martin Hrabec
(1/2008, Case reports ) - THE COST OF HORMONAL THERAPY FOR PROSTATE CANCER – PHARMACOECONOMIC ASPECTS OF TREATMENT INDICATIONS
doc. MUDr. Miroslav Hanuš, CSc., MUDr. Michaela Matoušková
(1/2008, Review articles ) - Cyst of ejakulary duct, obstructive cause of anejaculation and prostatodynia
MUDr. David Čapka, MUDr. Otakar Štanc, MUDr. Robert Grill
(1/2021, Communication from practice ) - PET/CT scanning in patients with prostate cancer
MUDr. Václav Ptáčník, MUDr. Jozef Kubinyi, Ph.D., FEBNM
(1/2016, Review articles ) - Diagnostic algorithms in prostate cancer – 1st part
MUDr. Otakar Čapoun, Ph.D., FEBU
(2/2021, In short ) - Progression of prostate cancer after radical prostatectomy despite undetectable PSA levels
MUDr. Alexandra Jarošová, MUDr. Vladimír Študent, Ph.D., ml.
(2/2021, Communication from practice ) - Current treatment management of non-metastatic castration-resistant prostate cancer
MUDr. Nikol Rušarová, MUDr. Hana Študentová, Ph.D.
(1/2020, Review articles ) - Neuroendocrine prostate cancer with primary origin in the lungs
MUDr. Tomaš Chmelensky, MUDr. Pavel Hanek, MUDr. Karel Franěk, MUDr. Josef Rejlek, MUDr. Jiři Zvěřina
(2/2016, Communication from practice ) - Systemic radiotherapy for prostate cancer with bone metastases
MUDr. Otakar Čapoun, FEBU
(3/2016, Review articles ) - OBESITY, ADIPOCYTOKINES AND PROSTATE CANCER
MUDr. Daniel Housa
(1/2007, Review articles ) - Immunotherapy for prostate cancer
MUDr. Michal Podrazil, Ph.D., prof. MUDr. Radek Špíšek, Ph.D., prof. MUDr. Jiřina Bartůňková, DrSc.
(4/2016, Review articles ) - Prostate rebiopsy: when should be performed?
MUDr. Otakar Čapoun, Ph.D., FEBU
(3/2020, Practical advice ) - PROSTATITIS SYNDROME
MUDr. Kamil Belej, FEBU
(2/2007, Review articles ) - The tools assessing health-related quality of life in patients with prostate cancer
MUDr. Ján Švihra Jr.
(4/2016, Review articles ) - A new diagnostic algorithm in primary diagnosis of prostate cancer
MUDr. Šárka Kudláčková, Ph.D.
(2/2023, In short ) - Treatment of non-metastatic castration-resistant prostate cancer
MUDr. Ivo Kocák, Ph.D.
(4/2020, Review articles ) - Prostate abscess
MUDr. Jan Bartoň
(4/2020, Communication from practice ) - CHEMOTHERAPY OF HORMONALLY REFRACTORY PROSTATIC CARCINOMA
doc. MUDr. Jozef Mardiak, CSc.
(2/2007, Review articles ) - VÝSKYT LUTS A EREKTILNÍ DYSFUNKCE V OLOMOUCKÉM KRAJI
doc. MUDr. Vladimír Študent, Ph.D.
(2/2007, Case reports ) - The role of ARTAs in treating metastatic castration-resistant prostate cancer
MUDr. PharmDr. Jan Dvořák
(2/2019, Review articles ) - Intraluminal ureteral tumor with hydronephrosis, as presentation of a primary metastatic prostate carcinoma
MUDr. Petr Končický, MUDr. Jan Pokorný, FEBU, MBA, MUDr. Veronika Džundová, MUDr. Aleš Vopelka
(2/2019, Communication from practice ) - RELATIONSHIP BETWEEN PSA AND HISTOLOGICAL FINDIGS OF PROSTATE CANCER, BPH, PIN AND INFLAMMATION
MUDr. Ľubomír Lachváč, PhD., MUDr. Peter Bohuš, doc. MUDr. Ladislav Valanský, CSc., mim.prof., doc. MUDr. Vincent Nagy, CSc., MUDr. Miroslav Iláš, MUDr. Jaroslav Beck
(5-6/2007, Review articles ) - Have we found an optimal sequence in the treatment of metastatic castrationally-resistant prostate cancer?
MUDr. Tomaš Svoboda, Ph.D.
(1/2019, Review articles ) - COMBINATION DRUG THERAPY IN MEN WITH LOWER URINARY TRACT SYMPTOMS: CONTEMPORARY STATUS
doc. MUDr. Jozef Marenčák, PhD.
(5-6/2007, Review articles ) - NEW RECOMMENDATIONS FOR HORMONAL THERAPY OF PROSTATE CANCER IN COMBINATION WITH RADIOTHERAPY
MUDr. Viktor Vik, doc. MUDr. Roman Zachoval, Ph.D., MUDr. Vladislav Klemenc, MUDr. Miroslav Záleský
(5-6/2007, Review articles ) - Treatment of stress urinary incontinence in men after prostate surgery
doc. MUDr. Jozef Marenčák, PhD.
(4/2022, Review articles )
- Overview of treatment of castration-resistant prostate cancer
MUDr. Jana Obertová
(4/2012, Review articles ) - TECHNOLOGY DEVELOPMENT IN RADIATION THERAPY (part 2)
MUDr. Pavol Dubinský
(1/2008, Review articles ) - Biologic and targeted therapy for urogenital maliginities
MUDr. Mária Rečková
(1/2011, Review articles ) - Castration resistant prostate cancer in the year 2013
doc. MUDr. Jozef Marenčák, PhD.
(3/2013, Review articles ) - Chemotherapy of hormonally refractory prostatic carcinoma
doc. MUDr. Jozef Mardiak, CSc.
(1/2007, Review articles ) - Radium 223Ra in the treatment of bone malignancies
prof. MUDr. Ján Kliment, CSc., MUDr. Hubert Poláček, Ph.D., doc. MUDr. Ivan Režňák, CSc.
(5/2016, Review articles ) - Pitfalls of diagnosis and treatment of primary urothelial prostate cancer during the COVID-19 pandemic
MUDr. Peter Ščešňák, MUDr. Ivan Perečinsky, MUDr. Monika Daňová, PhD., doc. MUDr. Ivan Minčík, PhD.
(1/2022, Case reports ) - Screening of prostate cancer in the light of latest evidence
prof. MUDr. Peter Bujdák, CSc.
(3/2014, Main topic ) - Current recommendations for bisphosphonates therapy in cancer patients
prof. MUDr. Stanislav Špánik, CSc., MUDr. Beata Špániková, PhD.
(6/2013, Review articles ) - Proper selection of patients for Radium 223 and its role in metastatic castration-resistant prostate cancer treatment
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M., MUDr. Ján Slopovský
(2/2021, Review articles ) - Coffee consumption and prostate cancer risk: an updated meta-analysis
doc. MUDr. Peter Beržinec, CSc.
(3/2014, Information & comments ) - 18F-choline PET/CT in evaluation of therapeutic response of castration-resistant prostate cancer
Doc. MUDr. Soňa Balogová, PhD., MUDr. Lucia Noskovičová, MUDr. Lucia Kaliská FEBMN , MUDr. Marika Vereb, FEBMN, MUDr. Marek Bartovic
(3/2015, Review articles ) - Treatment of bone metastases in castration resistant prostate cancer – current view
doc. MUDr. Jozef Marenčák, PhD.
(3/2015, Review articles ) - Prostate cancer – development of the incidence and mortality compared to Slovakia with foreign
prof. MUDr. Dalibor Ondruš, DrSc., doc. RNDr. Martina Ondrušová, PhD.
(1/2013, Review articles ) - Non-metastatic castration-resistant prostate cancer
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M., MUDr. Ján Slopovský
(3/2019, Review articles ) - Primary treatment of metastatic prostate cancer
MUDr. Matej Hrnčár, MUDr. Marek Lafférs, MUDr. Jozef Breznický, MUDr. Ján Šulgan, MUDr. Juraj Sokol, PhD., PhD., MUDr. Juraj Chudej, PhD.
(5/2017, Review articles ) - Current opinions on chemotherapy for prostate cancer
doc. MUDr. Ján Ľupták, PhD.
(3/2011, Review articles ) - Lutetium-177-PSMA in therapy of metastatic prostate cancer
MUDr. Eva Takácsová, PhD.
(4/2022, Main topic ) - Immunotherapy and targeted treatment for metastatic, castration-resistant prostate cancer
MUDr. Ján Slopovský, JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2022, Main topic ) - Immunotherapy in prostate cancer
MUDr. Katarína Rejleková, PhD.
(5/2020, Review articles ) - Rare malignant tumors involving prostate
MUDr. Ján Slopovský, JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2019, Main topic ) - Robot assisted radical prostatectomy
MUDr. Boris Kollárik, PhD., FEBU
(4/2023, Main topic ) - What are the current trends in external beam radiotherapy for localized prostate cancer?
doc. MUDr. Pavol Dubinský, PhD., MHA
(4/2023, Main topic ) - Current treatment options for metastatic hormone-sensitive prostate cancer
MUDr. Jana Obertová, PhD.
(4/2023, Main topic ) - Review on castrate-resistant prostate carcinoma systemic therapy
Doc. JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2023, Main topic ) - Zaujímavosti zo zahraničnej literatúry
doc. MUDr. Peter Beržinec, CSc.
(5/2011, Information & comments ) - Surgical treatment of prostate cancer
MUDr. Vladimír Baláž, PhD.
(5/2019, Main topic ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - Optimization of radiotherapy of high-risk prostate cancer
doc. MUDr. Pavol Dubinský, PhD., MHA
(5/2019, Main topic ) - A comprehensive view of the treatment of metastatic hormone sensitive prostate cancer
prof. MUDr. Ján Kliment, CSc., MUDr. Ing. Monika Kuzma, MBA
(5/2019, Main topic ) - Brachytherapy in prostate cancer
MUDr. Pavol Lukačko, MUDr. Milan Obšitník, CSc., MUDr. Alžbeta Molnárová
(5/2019, Main topic ) - Current possibilities and view of treatment of castration refractory metastatic prostate cancer
MUDr. Radovan Barilla, PhD.
(5/2019, Main topic ) - Metastatic prostate cancer: principles of hormonal treatment
Doc. MUDr. Frederico Goncalves, PhD.
(4/2014, Main topic ) - Castration resistant prostate cancer – something new in the year 2014?
doc. MUDr. Jozef Marenčák, PhD.
(4/2014, Main topic ) - RADIOTHERAPY PROSTATE CANCER
MUDr. Pavol Dubinský, PhD.
(5/2008, Review articles ) - RADIOTHERAPY OF PROSTATIC CANCER
MUDr. Vladimír Malec, PhD.
(4/2006, Review articles ) - Position of radiotherapy in the treatment of generalized prostate cancer
MUDr. Viktor Rosenberg, PhD.
(3/2017, Review articles ) - Správy z podujatia ASCO Chicago 2014
prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková, MUDr. Patrik Palacka, PhD. MPH, MBA
(4/2014, Events ) - Treatment of patient with metastatic castrate refractory prostate cancer after androgen deprivation therapy failure
MUDr. Jozef Babeľa, PhD.
(S1/2019, Case reports ) - Death following brain metastases evolvement in patient with metastatic castration resistant adenocarcinoma of prostate treated by enzalutamide with low level PSA
MUDr. Roman Tomaškin, PhD.
(S1/2019, Case reports ) - Treatment of metastatic castrate-resistant prostate cancer with enzalutamide
MUDr. Klaudia Gočárová, PhD.
(S1/2019, Case reports ) - Favourable therapeutic response of enzalutamide in patient with metastatic castration resistant prostate cancer
MUDr. Martin Romančík, PhD., MPH
(S1/2019, Case reports ) - Enzalutamide in the treatment of metastatic castration-resistant prostate cancer
MUDr. Andrej Rosík, MUDr. Ladislav Slobodník
(S1/2019, Case reports ) - Molecular pathology of prostate carcinoma (part 2)
MUDr. Katarína Macháleková, doc. MUDr. Karol Kajo, PhD., Mgr. Petra Tilandyová, RNDr. Zora Lasabová, PhD., MUDr. Roman Tomaškin
(4/2009, Review articles ) - Selected trends in prostate cancer epidemiology in Slovakia
prof. MUDr. Ján Kliment, CSc., doc. RNDr. Martina Ondrušová, PhD., MPH, RNDr. Mária Pšenková, MPH
(4/2015, Main topic ) - Odporúčania Slovenskej onkologickej spoločnosti SLS pre použitie bisfosfonátov v liečbe solídnych nádorov
prof. MUDr. Stanislav Špánik, CSc.
(4/2009, Recommendations ) - Enzalutamide in treatment of the metastatic castration resistant prostate cancer
Doc. MUDr. Jozef Marenčák, PhD.
(6/2017, Drugs & drug classes ) - Contemporary trends in prostate brachytherapy
MUDr. Pavol Lukačko, Mgr. Jozef Grežďo, PhD., MUDr. Branislav Obšitník, PhD.
(4/2016, Review articles ) - It is necessary to treat each patient with localized prostate cancer?
Doc. MUDr. Juraj Fillo, PhD.
(5/2014, Review articles ) - Stereotactic ultrahypofractionated radiotherapy of prostate cancer
doc. MUDr. Pavol Dubinský, PhD., MHA
(2/2023, Review articles ) - Prothon therapy: still open questions
doc. MUDr. Pavol Dubinský, PhD.
(5/2015, Review articles ) - New possibilities and view for treatment of castration resistent prostate cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2012, Review articles ) - Exosomes – new topic in diagnostics of cancer
RNDr. Ján Sedlák, DrSc., Mgr. Martina Zdurienčíková, RNDr. Paulína Gronesová, PhD., RNDr. Dana Cholujová, PhD., RNDr. Ľuba Hunáková, CSc.
(5/2015, Review articles ) - Efficacy of darolutamide in the treatment castration sensitive prostate cancer
MUDr. Peter Leško, PhD.
(4/2024, Drugs & drug classes ) - Therapy of castration-resistant prostate cancer from the point of view of nuclear medicine
MUDr. Eva Takácsová, PhD., Mgr. Žaneta Kantová
(1/2024, Review articles ) - CURRENT GLOBAL AND LOCAL KNOWLEDGE AND PROBLEMS OF EPIDEMIOLOGY OF MALIGNANT TUMORS
doc. MUDr. Ivan Pleško, DrSc.
(1/2006, Review articles ) - Metastatic prostate cancer - new therapeutical approaches
MUDr. Patrik Palacka, PhD., MPH, MBA, Mgr. Soňa Herudová
(2/2015, Review articles ) - PET findings in rare prostate cancers – neuroendocrine prostate cancer – case report
MUDr. Andrej Vondrák, prof. MUDr. Ján Kliment, CSc., MUDr. Jozef Kubinyi, PhD, FEBNM
(4/2020, Case reports ) - PROSTATE CANCER – EPIDEMIOLOGY, ETIOLOGY, DIAGNOSTICS, CLINICAL SYMTOMPHS, SCREENING
prof. MUDr. Dalibor Ondruš, DrSc.
(1/2006, Review articles ) - Incidental prostate adenocarcinoma detected by transurethral resection of the prostate
MUDr. Branislav Trebatický, PhD., MUDr. Ivona Wilšinská, MUDr. Michaela Mihaľová, MUDr. Stanislav Žiaran, PhD., prof. MUDr. Peter Bujdák, PhD.
(4/2020, Original articles ) - Changes of bone mineral density in patients with testicular cancer
doc. MUDr. Jozef Mardiak, CSc., prof. MUDr. Juraj Payer, CSc., MUDr. Beata Špániková
(6/2012, Main topic ) - Radiotherapy of pelvic lymph node in high risk prostate cancer and local treatment in metastatic disease
doc. MUDr. Pavol Dubinský, PhD., MHA
(4/2020, Review articles ) - THE ROLE AND LIMITS OF PATHOLOGY IN ONCOLOGY
prof. MUDr. Lukáš Plank, CSc.
(1/2006, Review articles ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - Early prostate cancer: particularities of treatment
Doc. MUDr. Frederico Goncalves, PhD.
(1/2017, Review articles ) - Critical moments in the treatment of prostate cancer
MUDr. Marián Bernát
(6/2019, Review articles ) - Prostate cancer incidence and mortality in Slovakia and abroad
prof. MUDr. Dalibor Ondruš, DrSc., RNDr. Martina Ondrušová, PhD.
(5/2009, Review articles ) - Chemotherapy of hormone refractory prostate cancer
MUDr. Marta Škultétyová, MUDr. Andrea Mocná
(5/2009, Review articles ) - First-line treatment of metastatic castration-sensitive prostate cancer
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M., MUDr. Ján Slopovský
(3/2022, Review articles ) - Adjuvant therapy of prostate cancer
MUDr. Pavol Dubinský, PhD.
(5/2009, Review articles ) - Abiraterone in treatment of metastatic castrate resistant prostate cancer
prof. MUDr. Ján Kliment, CSc.
(2/2014, Drugs & drug classes ) - Management of sequential and combined treatment of a patient with metastatic prostate cancer
Doc. MUDr. Ján Breza, PhD.
(S1/2020, Case reports ) - Treatment of enzalutamide in the therapy of metastatic castration-resistant prostate cancer in postchemoindication
MUDr. Alexandra Szabová
(S1/2020, Case reports ) - CARCINOMA OF THE VULVA – CLASSIFICATION AND CHARACTERISTICS
prof. MUDr. Ľudovít Danihel, PhD., MUDr. Vladimír Šišovský, PhD., MUDr. Michal Palkovič, PhD., Dimitris Hatzibougias, M.D.
(6/2007, Review articles ) - Treatment of patient with metastatic prostate cancer – from sensitive to castration resistant disease – case report
MUDr. Vladimír Lenko, PhD., FEBU
(S1/2020, Case reports ) - Management of PSA progression after topical treatment of prostate cancer
doc. MUDr. Pavol Dubinský, PhD., MHA
(S1/2020, Case reports ) - PROSTATE SPECIFIC ANTIGEN (PSA) – SITUATION IN THE YEAR 2007
MUDr. Ivan Kolombo, FEBU, MUDr. Martina Poršová, MUDr. Iva Zemanová, MUDr. Miloš Horecký, MUDr. Petra Antonová, MUDr. Tomáš Vlásek, MUDr. Jaroslav Porš
(6/2007, Review articles ) - Image guided brachytherapy
MUDr. Pavol Lukačko, Mgr. Jozef Grežďo, PhD.
(2/2016, Main topic ) - Stereotactic body radiotherapy
doc. MUDr. Pavol Dubinský, PhD., MUDr. Martin Jasenčák
(2/2016, Main topic ) - Molecular pathology of prostate carcinoma (part 1)
MUDr. Katarína Macháleková, doc. MUDr. Karol Kajo, PhD, Mgr. Petra Tilandyová, RNDr. Zora Lasabová, PhD., MUDr. Roman Tomaškin
(3/2009, Review articles ) - Role of hormonal treatment in non-metastatic prostate cancer
MUDr. Ivan Dekánek
(6/2018, Review articles ) - CONTEMPORARY POSSIBILITY OF THE TREATMENT OF BONE METASTASES
prof. MUDr. Ľudovít Jurga, CSc.
(3/2007, Review articles - treatment ) - Glukokortikoidy v liečbe kastračne-rezistentného karcinómu prostaty a mechanizmy rezistencie na androgénnu blokádu
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2018, Review articles ) - PROSTATE CANCER – PRINCIPLE OF HORMONE THERAPY
prof. MUDr. Michal Horňák, DrSc.
(3/2006, Review articles ) - Androgen deprivation therapy and radiotherapy of prostate cancer
doc. MUDr. Pavol Dubinský, PhD.
(5/2018, Review articles )
- PHARMACOTHERAPY OF BENIGN PROSTATIC HYPERPLASIA, PREVENTION, EFFECTIVE MEDICATIONS, ADVERSE EVENTS
MUDr. Miloš Broďák, MUDr. Lukáš Holub
(2/2007, clearly ) - NEW POSSIBILITIES OF VENOUS THROMBOEMBOLISM PROPHYLAXIS AND TREATMENT FOR THE KNEE AND HIP ARTHROPLASTY IN ORTHOPEDIC SURGERY
doc. MUDr. Ján Staško, PhD., prof. MUDr. Peter Kubisz, DrSc., MUDr. Daniela Kotuličová
(4/2008, Review articles ) - METABOLIC SYNDROME AND SELECTED MENTHAL ILLNESSES
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(4/2008, Review articles )
- Current possibilities of benign prostatic hyperplasia therapy part II.
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Lucia Masaryková, PharmDr. Ľubica Lehocká, PhD.
(4/2012, Current pharmacotherapy ) - Current possibilities of benign prostatic hyperplasia therapy part I.
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Lucia Masaryková, PharmDr. Ľubica Lehocká, PhD.
(3/2012, Current pharmacotherapy )